Analyzer and reagent solutions serve small to very large volume laboratories with diagnostic products and services for clinical chemistry and immunoassay. We’ve designed our analytical systems to optimize your resources and minimize the number of sample tubes processed, while providing high-quality results and valued clinical information to the physician and patient.
Get more done in less time within your laboratory’s existing floor plan by integrating clinical chemistry and immunoassay testing into a single platform to ramp up efficiency and by consolidating workstations to enhance your laboratory’s performance.
When combined into a coordinated system to meet your unique requirements, Roche Diagnostics Serum Work Area (SWA) integrated systems improve service delivery and quality while streamlining workflow, reducing stress on laboratory personnel and management and contributing to patient care excellence.
You are expected to manage an increasing number of samples and provide high-quality results fast. However, you are faced with limited time and space, your team is pushed to their limits, and you have to deal with a highly unpredictable future.
To help you overcome these challenges, we proudly introduce our newest generation of the cobas® pro integrated solutions. Experience an unprecedented level of simplicity.
Now with our newest analytical units, the cobas® c 703 and cobas® ISE neo analytical units, we are taking the cobas® pro to the next level in high-volume clinical chemistry testing. With a high throughput, reduced maintenance efforts, and expanded testing services, your team’s time is freed up.
The new and smart concept of self-operating maintenance executes maintenance tasks automatically in the background and reduces the manual burden of daily maintenance to zero for cobas® c c503, cobas® c 703 and cobas® ISE neo analytical units, and to only five minutes for cobas® e 801 analytical unit.
24-hour uninterrupted operation¹
Continuous loading of reagents and consumables
Automated maintenance that requires only 5 minutes of daily operator intervention²
Automated calibration with cobas® AutoCal
1. Data on file. Roche Diagnostics International Ltd.
2. cobas® pro integrated solutions user guide. Roche Diagnostics GmbH, Germany
Today more than ever, the importance of accurate and timely diagnostics is clearly understood. The journey from blood collection to the final test result, however, requires the highest level of dedication, expertise and diligence of the laboratory staff.
To support you in this, Roche has developed innovative integrated solutions renowned for quality and excellence.
cobas® pure integrated solutions is the newest member of the cobas® family of systems which is designed to deliver excellence, while at the same time simplifying your daily work. cobas® pure combines clinical chemistry, immunochemistry and ISE testing on a footprint of just 2 square meters, giving access to our broad menu of more than 230 parameters - including many unique high medical value value assays to labs who have to deal with limited space.
To simplify daily operation, cobas® pure comes with new features that minimize the hands on work for the operators, thus saving precious time.
To ensure simple and effective work for network organizations, cobas® pure provides fully standardized results and operation to cobas® pro integrated solutions - Roches’s latest analyzer designed for larger labs.
Because simplifying any step of the journey can help deliver fast and accurate diagnosis
Mass spectrometry is a versatile and advantageous diagnostic tool found in a clinical laboratory. It can be used in certain clinical situations, such as measuring steroid hormones in endocrinology, testing vitamin D, and monitoring immunosuppressants and therapeutic drugs. The high specificity and sensitivity of the tests can provide physicians with greater levels of clarity, which in turn can benefit patients through more precise and accurate results.
Mass spectrometry is considered a gold standard in certain clinical situations¹, but many laboratories are unable to use it because current solutions are too complex, lack integration and standardization, and require highly trained personnel. Until now, no fully automated and standardized solution was available.
With the cobas® Mass Spec solution, which includes the cobas® i 601 analyzer and the Ionify® reagents line, you can step away from tedious and complex manual mass spectrometry workflows and experience the simplicity and convenience of a streamlined end-to-end solution.
A broad assay menu of Ionify reagents is in development, complementing the clinical chemistry and immunoassay portfolio available on cobas® pro integrated solutions. The assays include ready-for-use test kits with consistent performance and traceability to reference methods.
Reference:
Rankin-Turner S. and Heaney L. (2023). CCLM 61, 873-879. Available from: https://www.degruyter.com/document/doi/10.1515/cclm-2022-0984/html
The cobas® e411analyzer series is an immunoassays system. Designed with the flexibility to expand operations for busier workloads, the cobas® e411analyzer series can process 50 to 400 samples per day. In addition, access to Roche's broad and growing assay menu ensures the necessary tests are available for your patients when needed.
Accurate results the first time Using patented electrochemiluminescence (ECL) technology – with one of the broadest measuring ranges in the industry. High-quality reagents, clot detection, re-run, reflex testing and carry-over protection ensure accurate results the first time.
Quality of results Using disposable tips and cups virtually eliminates the potential for carry-over
Empowered by cobas brand commonality Intuitive user interface and convenient liquid ready-to-use reagents are common to all cobas eanalyzers allowing minimal training and optimal productivity.
Designed for a dedicated task, with a throughput of up to 400 HbA1c patient results per hour, the cobas c 513 analyzer manages the workload of labs with high to very high HbA1c workload.
The cobas® c 513 analyzer runs the established Roche Tina-quant® HbA1c test, which is standardized according to IFCC and transferable to DCCT/NGSP in order to ensure high quality and standardized results. With no interference from most commonly known HbA1c variants, Roche’s Tina-quant® HbA1c assay delivers accurate results for risk identification and monitoring of long-term blood glucose control. It can also be used as an aid in the diagnosis of diabetes and identifying patients who may be at risk for developing diabetes. The assay delivers results that clinicians and patients can trust.
With over 50 years of innovation in clinical chemistry, immunodiagnostics and automated diagnostic systems, Roche’s Professional Diagnostics equips diagnostic laboratories around the world with a wide portfolio of more than 220 assays to measure hundreds of different parameters in blood, serum, or urine, while minimizing costs.
Analyzers and reagents include immunology and clinical chemistry systems for commercial labs, hospital core labs, medical centers and laboratory networks.
In Clinical Chemistry you will find information about the Roche cobas® c 503 and c 703 (cobas® pro integrated solutions) and the cobas® c 303 (cobas® pure integrated solutions). We are proud of our continuously growing pipeline of different disease management products. In addition, cobas® pro integrated solutions and cobas® pure integrated solutions use the same reagents kits for a true standardization of your laboratory.
Enzymes and Substrates
Specific Proteins
TDM and DAT
Specialty Assays
In immunology you will find information about the ECL Technology* base for the cobas® e 801 analyzer (cobas® pro integrated solutions), cobas®e 402 (cobas® pure integrated solutions), and the cobas e 411 analyzer. We are proud of our continuously growing pipeline of different Disease Management products. In addition, cobas® pro integrated solutions and cobas® pure integrated solutions use the same reagents kits for a true standardization of your laboratory:
Thyroid Function
Fertility/Hormones
Tumor Markers
Cardiac Markers
Anemia
Infectious Disease
Bone Markers
Inflammation Sepsis
Critical Care
Pregnancy
Since 1996 Electrochemiluminescence (ECL) technology has been Roche’s immunochemistry detection technology of choice. It was first used in the clinical laboratory on the Elecsys® 2010 analyzer with six immunoassay applications.
Today, ECL is the most successful chemiluminescence technology with more than 75 applications and 20,000 instrument placements worldwide. No other IVD company can offer an automated detection technology that matches ECL’s unique blend of controlled reaction, precision and sensitivity, low sample volume, wide measuring range and rapid measurement.